Skip to main content
Equibles

UBS Group AG

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1610520 ZURICH, V8
Back to ANIP Full portfolio

Position in ANIP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$24,630,277
-$13,643,005 QoQ
Shares Held
297,539
-40.2% QoQ
Ownership
1.30%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#17
of 305 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIP Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. ANIP ranks #13 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,643,241 $261,803,294
2 ELAN
Elanco Animal Health Inc
 9,910,822 $243,905,327
3 UTHR
UNITED THERAPEUTICS Corp
 220,616 $119,536,366
4 VTRS
Viatris Inc
 6,092,296 $96,745,659
5 LNTH
Lantheus Holdings, Inc.
 835,494 $92,689,703
6 HIMS
Hims & Hers Health, Inc.
 2,660,810 $92,250,281
7 NBIX
Neurocrine Biosciences Inc
 545,937 $92,012,220
8 TEVA
Teva Pharmaceutical Industries Ltd
 2,140,065 $72,505,400

All Filings in ANIP

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $24,630,277 297,539
2026-03-31 $38,273,282 497,702
2025-12-31 $11,902,493 150,779
2025-09-30 $54,032,458 589,874
2025-06-30 $26,406,805 404,702
2025-03-31 $17,700,908 264,390
2024-12-31 $32,881,094 594,810
2024-09-30 $17,091,872 286,488
2024-06-30 $2,036,103 31,974
2024-03-31 $1,207,147 17,462
2023-12-31 $1,049,368 19,031
2023-09-30 $358,694 6,178
2023-06-30 $1,726,487 32,073
2023-03-31 $464,604 11,697
2022-12-31 $274,246 6,817
2022-09-30 $1,414 44
2022-03-31 $13,520 481
2021-12-31 $271,916 5,901
2021-09-30 $53,397 1,627
2021-06-30 $82,717 2,360
2021-03-31 $143,222 3,963
2020-12-31 $144,996 4,993
2020-09-30 $225,143 7,981
2020-06-30 $581,796 17,990
2020-03-31 $310,316 7,617